Evidence suggests that virtually every organ system in the human body possesses a local renin–angiotensin system (RAS). These local systems seem to be independently regulated and compartmentalized ...
The renin–angiotensin–aldosterone system is a well-established therapeutic target in the treatment of heart failure (HF). Substantial advances have been made with existing ...
Today, nearly all patients with septic shock receive the same first-line therapy. However, early research suggests that some ...
Background: Hepatitis B virus (HBV) infection is a common cause of liver-related morbidity and mortality. Evidence suggests that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II ...
In this rapidly evolving setting, clinicians are weighing the alleged harm of continuing these medications in patients for whom ACE inhibitors and ARBs have known benefit against the harm to their ...
Explore the evolution of IgA nephropathy treatment, highlighting new guidelines and targeted therapies that improve patient outcomes.
Verywell Health on MSN
How obesity affects your blood pressure (and what you can do about it)
Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Obesity can increase the heart's workload, leading to high blood ...
Angiotensin II receptor antagonists are agents used to modify the renin-angiotensin-aldosterone system (RAAS) through blocking angiotensin receptors. This has the effect of lowering blood pressure.
Angiotensin receptor blockers are antihypertensive medicines used to treat high blood pressure. They act as vasodilators, widening the blood vessels (vasodilation) and reducing blood pressure. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback